Chuo Shinkin Venture Capital
VC Fund
Chuo Shinkin Venture Capital is a venture fund of Kyoto Chuo Shinkin Bank
- Total investments:
- 9
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Chuo Shinkin Venture Capital invests in
Stages Chuo Shinkin Venture Capital invests in
Countries Chuo Shinkin Venture Capital invests in
Round sizes
Round size
- Series A
- $20M–$128M
Investment Focus
Industry
- Medical 2 (22%)
- Health Care 2 (22%)
- Life Science 2 (22%)
- Manufacturing 2 (22%)
- GPS 1 (11%)
Stage
- Series A 4 (44%)
- Series B 2 (22%)
- Seed 1 (11%)
- Funding Round 1 (11%)
- Venture - Series Unknown 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| HACARUS is a provider of Explainable Lightweight AI Tools, backed by Miyako Capital (Kyoto University) among others. Its solutions are used in the Medical and Manufacturing fields to enable humans to make better, faster and more reliable decisions, based on AI driven insights. Hacarus' proprietary AI engine is built using Sparse Modeling, anAI method that understands data like a human would - by its unique key features and is far more resource, time and energy efficient when compared to Deep Learning. | $12.4M / Series B / Nov 16, 2020 | ||
| Regional Fish provides seed, seedlings, aquaculture methods and fisheries services. | $3.8M / Series A / Aug 31, 2020 | ||
| Thyas Co. Ltd. provides preparations of regenerative immunocell therapy for cancer and infection. | $2.2M / Venture - Series Unknown / Nov 20, 2019 | ||
| Space Power Technologies (SPT) was founded in 2019 as Japan's first start-up for “Spatial Transmission Wireless Power Transmission (WPT)”. We will harmonize elemental technologies cultivated through academics with people and society, and solve social issues related to power supply. | Seed / Sep 04, 2019 | ||
| Atomis provides global solutions for precisely controlling gases. Its core technology, porous coordination polymers (PCPs; also known as metal-organic frameworks (MOFs)), is based on research developed by Distinguished Professor Susumu Kitagawa at the Institute for Advanced Study at Kyoto University. It aims not only to provide solutions such asthe optimization for manufacturing processes of PCPs but to also develop applications that provide innovative value using these materials.It was founded by Masakazu Higuchi in 2015 and is headquartered in Kyoto, Japan. | $3.2M / Series A / Jul 01, 2019 | ||
| AlphaNavi Pharma specializes in the research and development of new drugs. | $8.1M / Series A / Apr 05, 2019 | ||
| AFI Technology develops and supplies microbial testing systems and particle separation technologies for applications in biotechnology, pharmaceuticals, and quality control. The company provides equipment such as the PixeeMo-nX, which enables rapid detection and quantification of viable microorganisms using automated imaging and analysis functions.Its technology separates and captures microorganisms from complex samples through electrical and fluid control methods, allowing detailed measurement and evaluation. AFI Technology also supports processes involving concentration and recovery of microorganisms for further study, including samples that are difficult to culture. The company focuses on integrating analytical systems with research and production workflows that require precise microbial assessment. | $61M / Series B / Feb 13, 2018 | ||
| RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer . | $2.9M / Aug 04, 2017 | ||
| Stroly is a map platform that allows you to experience and share the diverse stories within the place. With the birth of smartphones and map apps, it became easier to acknowledge their locations. The map apps function as tools to provide accurate information about your destination and your current location. However, the information provided by appscannot share the stories of how the people living there have felt and thought throughout the time. Also, it is hard to imagine the shape of the city and what kind of stories will be created in the future. | $19.8M / Series A / May 17, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Chuo Shinkin Venture Capital invest in?
Chuo Shinkin Venture Capital invests primarily in Medical, Health Care and Life Science startups, most often at Series A and Series B stage. Most of the 9 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Chuo Shinkin Venture Capital's check size?
Chuo Shinkin Venture Capital typically joins rounds of $20M–$128M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Chuo Shinkin Venture Capital participates in.
When did Chuo Shinkin Venture Capital last invest?
The most recent investment recorded for Chuo Shinkin Venture Capital closed in Nov 2020. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
